PLUS THERAPEUTICS, INC. — Director's Dealing 2025

Oct 3, 2025

SEC Form 4/A — Form 4/A

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2025-08-13

Reporting Person: HEDRICK MARC H (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-13	Stock Option (Right to Buy)	$0.5744	A	5748506	Acquired	2035-08-12	Common Stock (5748506)	Direct
2025-08-13	Restricted Stock Units	$	A	1916168	Acquired		Common Stock (1916168)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

F2: This amendment is being filed to correct a Form 4 filed on August 15, 2025, which inadvertently disclosed the incorrect vesting terms of the Restricted Stock Units ("RSUs"). The RSUs awarded on August 13, 2025 vest over twelve quarters, vesting in substantially equal 1/12th increments beginning with the quarter ended September 30, 2025. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.